Identification of hepatological and metabolical risk factors in patients with a ventricular assist device

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00004264

Enrollment

Registered

2014-03-28

Start date

2011-10-27

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Therapy refractory heart failure Z95.80

Interventions

Group 1: Patients with terminal heart failure who have an indication for the implantation of a ventricular assist device.

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with an indication for the implantation of a ventricular assist device, written informed consent of the patient or a legally certain attendant

Exclusion criteria

Exclusion criteria: no indication for the implantation of a ventricular assist device, missing informed consent

Design outcomes

Secondary

Measure	Time frame
Liver dysfunction defined as bilirubin >51 µmol/l, Albumin <28 g/l, ICG-PDR <10 %/min on POD 3 and 7.	—

Primary

Measure	Time frame
Survival after 100 days	—

Countries

Germany

Contacts

Public ContactAndrea Schneider

Medizinische Hochschule Hannover

andrea.s.schneider@gmx.de0511 532 3806

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026